Cargando…
Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study
OBJECTIVES: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) level is a marker of oxidative stress and is linked to progression of arteriosclerosis; however, the clinical factors affecting the oxidised LDL level have not been elucidated. We investigate various factors to identify correlati...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305066/ https://www.ncbi.nlm.nih.gov/pubmed/25609666 http://dx.doi.org/10.1136/bmjopen-2014-005455 |
_version_ | 1782354178140536832 |
---|---|
author | Ogawa, Kazuo Tanaka, Toshikazu Nagoshi, Tomohisa Sekiyama, Hiroshi Arase, Satoshi Minai, Kosuke Ogawa, Takayuki Yoshimura, Michihiro |
author_facet | Ogawa, Kazuo Tanaka, Toshikazu Nagoshi, Tomohisa Sekiyama, Hiroshi Arase, Satoshi Minai, Kosuke Ogawa, Takayuki Yoshimura, Michihiro |
author_sort | Ogawa, Kazuo |
collection | PubMed |
description | OBJECTIVES: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) level is a marker of oxidative stress and is linked to progression of arteriosclerosis; however, the clinical factors affecting the oxidised LDL level have not been elucidated. We investigate various factors to identify correlation with MDA-LDL level in high-risk patients requiring catheter intervention. SETTING: Secondary care (cardiology), single-centre study. PARTICIPANTS: 600 patients who were admitted to our hospital and underwent cardiac catheterisation. PRIMARY AND SECONDARY OUTCOME MEASURES: Blood samples were obtained to measure lipid profiles and MDA-LDL level. RESULTS: With regard to smoking status, MDA-LDL level was significantly higher in ex-smokers/current smokers compared with non-smokers. Of note, there was no improvement of MDA-LDL level even in patients who had quit smoking. Multiple regression analysis showed that MDA-LDL level was positively correlated with LDL-cholesterol (LDL-C) level, Brinkman index and male gender. The correlation between smoking status and either MDA-LDL or LDL-C level was investigated in two groups: namely, patients with and patients without statin treatment. In the non-statin group, MDA-LDL level and MDA-LDL/LDL-C ratio were significantly higher in ex-smokers/current smokers compared with non-smokers, while no significant correlation was observed between smoking status and LDL-C level. In contrast, in the statin group, there were no significant correlations between smoking status and any of the cholesterol parameters. CONCLUSIONS: We found that MDA-LDL level was affected by multiple factors, such as smoking status, LDL-C level and male gender. The present findings give additional evidence that smoking should be prohibited from a MDA-LDL standpoint. Furthermore, statin therapy might have a beneficial effect on the reduction of MDA-LDL level. |
format | Online Article Text |
id | pubmed-4305066 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-43050662015-01-28 Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study Ogawa, Kazuo Tanaka, Toshikazu Nagoshi, Tomohisa Sekiyama, Hiroshi Arase, Satoshi Minai, Kosuke Ogawa, Takayuki Yoshimura, Michihiro BMJ Open Cardiovascular Medicine OBJECTIVES: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) level is a marker of oxidative stress and is linked to progression of arteriosclerosis; however, the clinical factors affecting the oxidised LDL level have not been elucidated. We investigate various factors to identify correlation with MDA-LDL level in high-risk patients requiring catheter intervention. SETTING: Secondary care (cardiology), single-centre study. PARTICIPANTS: 600 patients who were admitted to our hospital and underwent cardiac catheterisation. PRIMARY AND SECONDARY OUTCOME MEASURES: Blood samples were obtained to measure lipid profiles and MDA-LDL level. RESULTS: With regard to smoking status, MDA-LDL level was significantly higher in ex-smokers/current smokers compared with non-smokers. Of note, there was no improvement of MDA-LDL level even in patients who had quit smoking. Multiple regression analysis showed that MDA-LDL level was positively correlated with LDL-cholesterol (LDL-C) level, Brinkman index and male gender. The correlation between smoking status and either MDA-LDL or LDL-C level was investigated in two groups: namely, patients with and patients without statin treatment. In the non-statin group, MDA-LDL level and MDA-LDL/LDL-C ratio were significantly higher in ex-smokers/current smokers compared with non-smokers, while no significant correlation was observed between smoking status and LDL-C level. In contrast, in the statin group, there were no significant correlations between smoking status and any of the cholesterol parameters. CONCLUSIONS: We found that MDA-LDL level was affected by multiple factors, such as smoking status, LDL-C level and male gender. The present findings give additional evidence that smoking should be prohibited from a MDA-LDL standpoint. Furthermore, statin therapy might have a beneficial effect on the reduction of MDA-LDL level. BMJ Publishing Group 2015-01-21 /pmc/articles/PMC4305066/ /pubmed/25609666 http://dx.doi.org/10.1136/bmjopen-2014-005455 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Cardiovascular Medicine Ogawa, Kazuo Tanaka, Toshikazu Nagoshi, Tomohisa Sekiyama, Hiroshi Arase, Satoshi Minai, Kosuke Ogawa, Takayuki Yoshimura, Michihiro Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study |
title | Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study |
title_full | Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study |
title_fullStr | Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study |
title_full_unstemmed | Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study |
title_short | Increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study |
title_sort | increase in the oxidised low-density lipoprotein level by smoking and the possible inhibitory effect of statin therapy in patients with cardiovascular disease: a retrospective study |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305066/ https://www.ncbi.nlm.nih.gov/pubmed/25609666 http://dx.doi.org/10.1136/bmjopen-2014-005455 |
work_keys_str_mv | AT ogawakazuo increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy AT tanakatoshikazu increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy AT nagoshitomohisa increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy AT sekiyamahiroshi increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy AT arasesatoshi increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy AT minaikosuke increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy AT ogawatakayuki increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy AT yoshimuramichihiro increaseintheoxidisedlowdensitylipoproteinlevelbysmokingandthepossibleinhibitoryeffectofstatintherapyinpatientswithcardiovasculardiseasearetrospectivestudy |